What they do
Aesir is a Sydney corporate advisory and capital markets firm that advises high-growth, emerging, micro and small-cap companies on corporate advice and capital raisings.
- Services
- Equity raisings
- Deal size
- Recorded deals: median A$10m
- Clients
- Listed companies, Startups and venture-backed companies
- Licences
- Corporate Authorised Representative AR 001269084 of Urd Services Pty Ltd (AFSL 511904)
- Founded
- 2016
From aesircapital.com.au, checked 7 Nov 2026: /
Deals
Columns
1 of 1 deals
| Advisers | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2026 | Identifai Genetics | – | – | IPO | Lead manager | Listed | 10.0 | Biotech and pharmaceuticals | Nova Legal (issuer)Gornitzky (issuer)Herzog Patents (Cohn, de Vries, Stadler & Co.) (issuer)RSM (issuer)Pendragon Capital (issuer) | Identifai Genetics IPO |
Listed on their website
- Sole Lead Manager, $5M placement, Ailo $5M · 2019
- Sole Lead Manager, $5m initial public offer, Tempus Resources $5m · 2018
- Sole Lead Manager, $75m placement, GetSwift $75m · 2017
- Sole Lead Manager, $14m placement, Medibio $14m · 2017
- Joint Lead Manager, $3.9m placement, Celsius $3.9m · 2017
- Sole Lead Manager, $3m placement, Robo3D $3m · 2017
- Joint Lead Manager, US$100M Series B financing, Collinear Networks 2016
- Sole Lead Manager, $6M placement, Dubber $6M · 2016
Transactions the firm lists on its own website, checked 7 Nov 2026. Those FundComb has recorded link to the deal.
Offices and contact
Offices
- Sydney